RSAD2 Polyclonal Antibody

货号：ES4264
价格：面议
点击：2381

产品介绍

抗体信息

应用	WB;IHC-p;IF(paraffin section);ELISA
反应种属	Human;Rat;Mouse;
别称	RSAD2; CIG5; Radical S-adenosyl methionine domain-containing protein 2; Cytomegalovirus-induced gene 5 protein; Viperin; Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	550
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	548
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	502
Anti-Sarilumab Neutralizing Recombinant Antibody \|抗萨瑞鲁单抗中和重组抗体(靶标：萨瑞鲁单抗中和抗体)	505
Anti-Durvalumab Non-Neutralizing Recombinant Antibody \|程度伐利尤单抗非中和重组抗体(靶标：度伐利尤单抗非中和抗体)	840
Anti-Durvalumab Non-Neutralizing Recombinant Antibody \|抗度伐利尤单抗非中和重组抗体(靶标：度伐利尤单抗非中和抗体)	727
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	569
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	650
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	575
Anti-Durvalumab Neutralizing Recombinant Antibody \|抗度伐利尤单抗中和重组抗体(靶标：度伐利尤单抗中和抗体)	570
Anti-Atezolizumab Non-Neutralizing Recombinant Antibody \|抗阿替利珠单抗非中和重组抗体(靶标：阿替利珠单抗非中和抗体)	590
Anti-Atezolizumab Non-Neutralizing Recombinant Antibody \|抗阿替利珠单抗非中和重组抗体(靶标：阿替利珠单抗非中和抗体)	548
Anti-Atezolizumab Neutralizing Recombinant Antibody \|抗阿替利珠单抗中和重组抗体(靶标：阿替利珠单抗中和抗体)	527
Anti-Atezolizumab Neutralizing Recombinant Antibody \|抗阿替利珠单抗中和重组抗体(靶标：阿替利珠单抗中和抗体)	637
Anti-Panitumumab Non-Neutralizing Recombinant Antibody \|抗帕尼单抗非中和重组抗体(靶标：帕尼单抗非中和抗体)	770
Anti-Panitumumab Non-Neutralizing Recombinant Antibody \|抗帕尼单抗非中和重组抗体(靶标：帕尼单抗非中和抗体)	525
Anti-Panitumumab Non-Neutralizing Recombinant Antibody \|抗帕尼单抗非中和重组抗体(靶标：帕尼单抗非中和抗体)	512
Anti-Panitumumab Neutralizing Recombinant Antibody \|抗帕尼单抗中和重组抗体(靶标：帕尼单抗中和抗体)	456
Anti-Panitumumab Neutralizing Recombinant Antibody \|抗帕尼单抗中和重组抗体(靶标：帕尼单抗中和抗体)	488
Anti-Panitumumab Neutralizing Recombinant Antibody \|抗帕尼单抗中和重组抗体(靶标：帕尼单抗中和抗体)	458